Menu
GWAS Study

Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders.

Eijsbouts C, Zheng T, Kennedy NA et al.

34741163 PubMed ID
GWAS Study Type
2075908 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

EC
Eijsbouts C
ZT
Zheng T
KN
Kennedy NA
BF
Bonfiglio F
AC
Anderson CA
ML
Moutsianas L
HJ
Holliday J
SJ
Shi J
SS
Shringarpure S
VA
Voda AI
FG
Farrugia G
FA
Franke A
HM
Hübenthal M
AG
Abecasis G
ZM
Zawistowski M
SA
Skogholt AH
NE
Ness-Jensen E
HK
Hveem K
ET
Esko T
TM
Teder-Laving M
ZA
Zhernakova A
CM
Camilleri M
BG
Boeckxstaens G
WP
Whorwell PJ
SR
Spiller R
MG
McVean G
DM
D'Amato M
JL
Jostins L
PM
Parkes M
Chapter II

Abstract

Summary of the research findings

Irritable bowel syndrome (IBS) results from disordered brain-gut interactions. Identifying susceptibility genes could highlight the underlying pathophysiological mechanisms. We designed a digestive health questionnaire for UK Biobank and combined identified cases with IBS with independent cohorts. We conducted a genome-wide association study with 53,400 cases and 433,201 controls and replicated significant associations in a 23andMe panel (205,252 cases and 1,384,055 controls). Our study identified and confirmed six genetic susceptibility loci for IBS. Implicated genes included NCAM1, CADM2, PHF2/FAM120A, DOCK9, CKAP2/TPTE2P3 and BAG6. The first four are associated with mood and anxiety disorders, expressed in the nervous system, or both. Mirroring this, we also found strong genome-wide correlation between the risk of IBS and anxiety, neuroticism and depression (rg > 0.5). Additional analyses suggested this arises due to shared pathogenic pathways rather than, for example, anxiety causing abdominal symptoms. Implicated mechanisms require further exploration to help understand the altered brain-gut interactions underlying IBS.

53,400 European ancestry cases, 433,201 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

2075908
Total Participants
GWAS
Study Type
Yes
Replicated
205,252 European ancestry cases, 1,384,055 European ancestry controls
Replication Participants
European
Ancestry
Netherlands, Sweden, U.S., Belgium, Norway, Italy, U.K., Germany, Estonia
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.